Myriad Genetics News

Express News | Myriad Genetics Signs Agreement With Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Reuters16:30 ET

Investors in Myriad Genetics (NASDAQ:MYGN) From Five Years Ago Are Still Down 51%, Even After 4.3% Gain This Past Week

Simply Wall StJan 8 08:04 ET

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 8 08:00 ET

The University Of Texas MD Anderson Cancer Center And Myriad Genetics Announce A 5-Year Strategic Alliance To Accelerate The Clinical Evaluation And Development Of Myriad's Molecular Residual Disease Assay

BenzingaJan 7 08:03 ET

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

GlobeNewswireJan 6 08:00 ET

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 97% Above Its Share Price

Yahoo FinanceDec 24, 2024 05:44 ET

Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

GlobeNewswireDec 19, 2024 16:15 ET

Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?

Zacks Dec 17, 2024 05:30 ET

Myriad Genetics Is Maintained at Underperform by B of A Securities

Dow JonesDec 13, 2024 11:25 ET · Ratings

BofA Securities Maintains Myriad Genetics(MYGN.US) With Sell Rating, Cuts Target Price to $13

Moomoo NewsDec 13, 2024 08:33 ET · Ratings

Top Premarket Decliners

MT NewswiresDec 12, 2024 07:51 ET

Express News | Myriad Genetics Inc : Jefferies Cuts Target Price to $13 From $15

ReutersDec 12, 2024 01:47 ET

Reported Earlier, Myriad Genetics Engages Unitedhealthcare On Pharmacogenetic Testing Policy, Seeks Continued Access To Genesight In 2025

BenzingaDec 11, 2024 02:35 ET

Myriad Genetics Talks With UnitedHealthcare on Insurance Exclusion Might Extend Into 2025

WSJDec 10, 2024 19:01 ET

Myriad Genetics: During 3Q Earnings Call Provided Estimate of 2024 Fincl Impact of UNH's Updated Medical Policy, Myriad Reaffirms Estimate >MYGN

Dow JonesDec 10, 2024 18:37 ET

Myriad Genetics: Desire Resolution Ahead of Yr-End, But Discussions May Extend Into Early 2025 >MYGN

Dow JonesDec 10, 2024 18:37 ET

Myriad Genetics: Engaged in Dialogue With UNH Regarding Clinical Evidence Supporting Myriad's Proprietary and Clinically Differentiated Mental Health Medication Test GeneSight >MYGN

Dow JonesDec 10, 2024 18:37 ET

Myriad Genetics Engages With UnitedHealthcare on Access to GeneSight Test Following Policy Update

Quiver QuantitativeDec 10, 2024 18:30 ET

Express News | Myriad Genetics Provides Update on Discussions With Unitedhealthcare Regarding Medical Policy for Pharmacogenetic Testing

ReutersDec 10, 2024 18:26 ET

Myriad Genetics Provides Update on Discussions With UnitedHealthcare Regarding Medical Policy for Pharmacogenetic Testing

GlobeNewswireDec 10, 2024 18:26 ET